Fuji Keizai is reported to forecast that sales by foreign pharmaceutical companies in the Japanese market will increase by more than 7% in fiscal 2026. The focus is on sales trends for foreign pharmaceutical companies in Japan.
Fuji Keizai indicated that sales by foreign pharmaceutical companies in the Japanese market are expected to increase by more than 7% in fiscal 2026. The article focuses on changes in the sales scale of foreign pharmaceutical companies in the Japanese market. Against the backdrop of trends in Japan's pharmaceutical market over nearly 3 years, sales growth by foreign companies in the Japanese market is attracting attention.